World Health Organization (WHO) grade 4 adult-type diffuse glioma remains one of the most challenging malignancies to treat, demanding a multidisciplinary and evidence-based approach.

This activity includes four challenging cases in lymphoma and myeloma with a panel of expert radiation oncologists, including one in private practice, and a medical oncologist. 1. Urgent need for debulking in extramedullary relapse of multiple myeloma after BCMA-targeted CAR T-cell therapy.

Given the rarity of lymphomas, many clinicians are not using radiation therapy appropriately in the frontline setting.

The management of bladder cancer is evolving across the spectrum of disease and stage and this educational activity is extremely valuable to the ASTRO membership.

This activity explores the evolving role of imaging biomarkers in radiotherapy, focusing on their capacity to improve target delineation, systemically predict and monitor treatment responses, and inform personalized clinical decision making on adaptive platforms.

This activity brings together an international panel and multidisciplinary expertise to discuss the emerging role of SABR to the primary in renal cell carcinoma (RCC).